Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure. Borlaug BA, Blair J, Bergmann MW, Bugger H, et al. Circulation 2022 Mar 31. doi: 10.1161/CIRCULATIONAHA.122.059486.

Read + Share

Amedeo Smart

Independent Medical Education

Borlaug BA, Blair J, Bergmann MW, Bugger H, et al. Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure. Circulation 2022 Mar 31. doi: 10.1161/CIRCULATIONAHA.122.059486.
PMID: 35354306